Clinical Trials Directory

Trials / Completed

CompletedNCT00921505

Effect of Ibuprofen, Paracetamol and Their Combination on Radical Oxygen Species (ROS) Production

The Effect of Ibuprofen, Paracetamol and Their Combination on Reactive Oxygen Species (ROS)- Production in Leukocytes and Platelet Activation

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
7 (estimated)
Sponsor
Ullevaal University Hospital · Academic / Other
Sex
All
Age
18 Years – 35 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether paracetamol, ibuprofen or their combination can modify generation of radical oxygen species (ROS) from stimulated neutrophils.

Detailed description

Non-steroidal anti-inflammatory drugs (NSAID) are used to alleviate clinical inflammatory symptoms (e.g. pain, swelling and reduced function). Leukocytes, upon activation during inflammatory states, generate radical oxygen species (ROS) which primarily are intended for host defence against invading pathogens. Certain NSAID can modify the generation of ROS from stimulated neutrophils ranging form increased production to reduced production. Preliminary experiments in our laboratory have shown that different NSAIDs have opposing effects on the ability of leukocytes (granulocytes and monocytes) to produce ROS upon a standardized stimulus, i.e. phorbol myristate acetate (PMA). Paracetamol has a marked inhibitory effect and ibuprofen has a facilitating effect on ROS production. An inhibitory effect of paracetamol was also seen when examining platelet activation markers, whereas acetylsalicylic acid showed a clear enhancing effect in this respect. We want to examine if intake of paracetamol or ibuprofen in vivo have similar effects on leukocyte ROS production and platelet activation, respectively.

Conditions

Interventions

TypeNameDescription
DRUGIbuprofenTablet ibuprofen 400 mg oral single dose (1 tablet)
DRUGIbuprofenTablets (2 x 600 mg) oral single dose (2 tablets)
DRUGParacetamol (acetaminophen) 1000 mgTablets (2 x 500 mg) oral single dose (2 tablets)
DRUGParacetamol + ibuprofenTablets (ibuprofen 400 mg + paracetamol (acetaminophen) 2 x 500 mg) single oral dose (3 tablets)

Timeline

Start date
2009-05-01
Primary completion
2010-01-01
Completion
2010-01-01
First posted
2009-06-16
Last updated
2011-07-06

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT00921505. Inclusion in this directory is not an endorsement.